Literature DB >> 24993984

Airway cell involvement in intermittent hypoxia-induced airway inflammation.

C Philippe1, Y Boussadia, V Prulière-Escabasse, J F Papon, C Clérici, D Isabey, A Coste, E Escudier, M P d'Ortho.   

Abstract

PURPOSE: Respiratory inflammation has been described in patients with obstructive sleep apnea syndrome, but it is unknown whether the increased neutrophil and interleukin (IL)-8 levels observed in induced sputum reflect systemic or local airway inflammation. We assessed the potential role of resident cells in intermittent hypoxia-induced airway inflammation.
METHODS: Airway epithelial cells (AEC) and bronchial smooth muscle cells (BSMC) were exposed to intermittent hypoxia (IH) in vitro. Cell supernatants were assessed for matrix metalloproteinase, growth factor, and cytokine expression. The role of IH on neutrophil and BSMC migration capacities was evaluated, and the effect of supernatants from IH-exposed or control AEC was tested.
RESULTS: Compared to normoxic conditions, 24 h of exposure to IH induced a significant increase of MMP-9 and MMP-2 expression and pro-MMP-9 activation (p < 0.05), and IL-8 (p < 0.05), platelet-derived growth factor (PDGF)-AA (p < 0.05), and vascular endothelial growth factor (VEGF) (p < 0.05) expression by AEC and VEGF expression (p = 0.04) by BSMC. Neutrophil chemotaxis and BSMC migration were enhanced by IH and supernatants of IH-exposed AEC (112.00 ± 4.80 versus 0.69 ± 0.43 %, p = 0.0053 and 247 ± 76 versus 21 ± 23, p = 0.009 respectively). This enhanced BSMC migration was totally abolished in the presence of an antibody blocking PDGF-AA.
CONCLUSIONS: These data suggest a specific inflammatory response of airway cells to IH, independently of systemic events.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24993984     DOI: 10.1007/s11325-014-1019-4

Source DB:  PubMed          Journal:  Sleep Breath        ISSN: 1520-9512            Impact factor:   2.816


  30 in total

1.  Inflammatory cells as well as epithelial cells in nasal polyps express vascular endothelial growth factor.

Authors:  A Coste; L Brugel; B Maître; S Boussat; J F Papon; L Wingerstmann; R Peynègre; E Escudier
Journal:  Eur Respir J       Date:  2000-02       Impact factor: 16.671

Review 2.  Obstructive sleep apnea: an emerging risk factor for atherosclerosis.

Authors:  Luciano F Drager; Vsevolod Y Polotsky; Geraldo Lorenzi-Filho
Journal:  Chest       Date:  2011-08       Impact factor: 9.410

3.  Matrix metalloproteinase gelatinases in sulfur mustard-induced acute airway injury in guinea pigs.

Authors:  J H Calvet; E Planus; P Rouet; S Pezet; M Levame; C Lafuma; A Harf; M P D'Ortho
Journal:  Am J Physiol       Date:  1999-05

4.  Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome.

Authors:  Silke Ryan; Cormac T Taylor; Walter T McNicholas
Journal:  Circulation       Date:  2005-10-25       Impact factor: 29.690

5.  Increased 8-isoprostane and interleukin-6 in breath condensate of obstructive sleep apnea patients.

Authors:  Giovanna E Carpagnano; Sergei A Kharitonov; Onofrio Resta; Maria P Foschino-Barbaro; Enzo Gramiccioni; Peter J Barnes
Journal:  Chest       Date:  2002-10       Impact factor: 9.410

6.  Systemic and airway inflammation in sleep apnea and obesity: the role of ICAM-1 and IL-8.

Authors:  Giovanna E Carpagnano; Antonio Spanevello; Roberto Sabato; Annarita Depalo; Grazia P Palladino; Laura Bergantino; Maria P Foschino Barbaro
Journal:  Transl Res       Date:  2010-01       Impact factor: 7.012

7.  Delayed neutrophil apoptosis in patients with sleep apnea.

Authors:  Larissa Dyugovskaya; Andrey Polyakov; Peretz Lavie; Lena Lavie
Journal:  Am J Respir Crit Care Med       Date:  2007-11-15       Impact factor: 21.405

8.  Involvement of fibronectin and matrix metalloproteinases in airway smooth muscle cell migration for the process of airway remodeling.

Authors:  Machiko Nishihara-Fujihara; Shunsuke Shoji; Iori Maeda; Terufumi Shimoda; Sankei Nishima; Kouji Okamoto
Journal:  Allergol Int       Date:  2010-05-25       Impact factor: 5.836

9.  Airway inflammation in patients affected by obstructive sleep apnea syndrome.

Authors:  F G Salerno; E Carpagnano; P Guido; M R Bonsignore; A Roberti; M Aliani; A M Vignola; A Spanevello
Journal:  Respir Med       Date:  2004-01       Impact factor: 3.415

10.  Nuclear factor-kappaB activation in airway epithelium induces inflammation and hyperresponsiveness.

Authors:  Cristen Pantano; Jennifer L Ather; John F Alcorn; Matthew E Poynter; Amy L Brown; Amy S Guala; Stacie L Beuschel; Gilman B Allen; Laurie A Whittaker; Mieke Bevelander; Charles G Irvin; Yvonne M W Janssen-Heininger
Journal:  Am J Respir Crit Care Med       Date:  2008-02-08       Impact factor: 21.405

View more
  9 in total

1.  Nasal nitric oxide in sleep-disordered breathing in children.

Authors:  Guy Gut; Riva Tauman; Michal Greenfeld; Keren Armoni-Domany; Yakov Sivan
Journal:  Sleep Breath       Date:  2015-05-07       Impact factor: 2.816

2.  Vascular endothelial growth factor levels in patients with obstructive sleep apnea: a meta-analysis.

Authors:  Xiao-Bin Zhang; Xing-Tang Jiang; Fang-Rong Cai; Hui-Qing Zeng; Yan-Ping Du
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-05-28       Impact factor: 2.503

Review 3.  Inflammation in sleep apnea: an update.

Authors:  Dileep Unnikrishnan; Jonathan Jun; Vsevolod Polotsky
Journal:  Rev Endocr Metab Disord       Date:  2015-03       Impact factor: 6.514

4.  Antero-cervical thermophysiological characterization of obstructive sleep apnea patients.

Authors:  Mariana Jarnalo; Ricardo Vardasca; Joaquim Gabriel Mendes; Marta Drummond
Journal:  Sleep Breath       Date:  2018-02-23       Impact factor: 2.816

5.  Alteration of Inflammatory Mediators in the Upper and Lower Airways under Chronic Intermittent Hypoxia: Preliminary Animal Study.

Authors:  Eun Jung Lee; Woon Heo; Joo Young Kim; Hyungchul Kim; Min Jung Kang; Bo Ra Kim; Ji Hyun Kim; Do Yang Park; Chang-Hoon Kim; Joo-Heon Yoon; Hyung-Ju Cho
Journal:  Mediators Inflamm       Date:  2017-09-06       Impact factor: 4.711

6.  Patients with Obstructive Sleep Apnea Have Altered Levels of Four Cytokines Associated with Cardiovascular and Kidney Disease, but Near Normal Levels with Airways Therapy.

Authors:  Ye Wang; Richard B Meagher; Suresh Ambati; Huimin Cheng; Ping Ma; Bradley G Phillips
Journal:  Nat Sci Sleep       Date:  2021-03-25

7.  Obstructive Sleep Apnoea Modulates Airway Inflammation and Remodelling in Severe Asthma.

Authors:  Camille Taillé; Anny Rouvel-Tallec; Maria Stoica; Claire Danel; Monique Dehoux; Viviana Marin-Esteban; Marina Pretolani; Michel Aubier; Marie-Pia d'Ortho
Journal:  PLoS One       Date:  2016-03-02       Impact factor: 3.240

8.  Serum Levels of Vascular Endothelial Growth Factor and Insulin-like Growth Factor Binding Protein-3 in Obstructive Sleep Apnea Patients: Effect of Continuous Positive Airway Pressure Treatment.

Authors:  Kostas Archontogeorgis; Evangelia Nena; Nikolaos Papanas; Maria Xanthoudaki; Olga Hatzizisi; Georgios Kyriazis; Venetia Tsara; Efstratios Maltezos; Marios Froudarakis; Paschalis Steiropoulos
Journal:  Open Cardiovasc Med J       Date:  2015-12-29

Review 9.  Technical Feasibility and Physiological Relevance of Hypoxic Cell Culture Models.

Authors:  Jiri Pavlacky; Jan Polak
Journal:  Front Endocrinol (Lausanne)       Date:  2020-02-21       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.